Indication
Enterobacter peritonitis
Enterobacter peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Enterobacter*, most commonly members of the *Enterobacter cloacae* complex. Read more about Enterobacter peritonitis
46 drugs 34 manufacturers
Drugs that treat it
Common Enterobacter peritonitis therapies.
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
AMPICILLIN-SULBACTAM (ampicillin sodium/sulbactam sodium)
AZTREONAM
AZTREONAM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEnterobacter peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Enterobacter*, most commonly members of the *Enterobacter cloacae* complex.
It predominantly affects individuals undergoing peritoneal dialysis as a complication of catheter contamination or enteric transmural migration, as well as hospitalized patients developing secondary peritonitis following gastrointestinal perforation, anastomotic leak, or abdominal surgery.
Clinically, the condition manifests with abdominal pain, tenderness, fever, and cloudy peritoneal effluent or ascitic fluid with marked neutrophilic pleocytosis.
Pathophysiologically, it is notable for severe local peritoneal injury, systemic inflammatory response, and an elevated risk of clinical failure due to the organism's intrinsic potential for inducible chromosomal AmpC beta-lactamase-mediated resistance.
- nih.gov
Enterobacter peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Enterobacter*, most commonly members of the *Enterobacter cloacae* complex It predominantly affects individuals undergoing peritoneal dialysis as a complication of catheter contamination or enteric transmural migration, as well as hospitalized patients developing secondary peritonitis following gastrointestinal perforation, anastomotic leak,...
- mayoclinic.org
Enterobacter peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Enterobacter*, most commonly members of the *Enterobacter cloacae* complex It predominantly affects individuals undergoing peritoneal dialysis as a complication of catheter contamination or enteric transmural migration, as well as hospitalized patients developing secondary peritonitis following gastrointestinal perforation, anastomotic leak,...
- tandfonline.com
Enterobacter peritonitis is an acute intra-abdominal infection characterized by inflammation of the peritoneum caused by Gram-negative bacilli of the genus *Enterobacter*, most commonly members of the *Enterobacter cloacae* complex
- nih.gov
It predominantly affects individuals undergoing peritoneal dialysis as a complication of catheter contamination or enteric transmural migration, as well as hospitalized patients developing secondary peritonitis following gastrointestinal perforation, anastomotic leak, or abdominal surgery
- nih.gov
It predominantly affects individuals undergoing peritoneal dialysis as a complication of catheter contamination or enteric transmural migration, as well as hospitalized patients developing secondary peritonitis following gastrointestinal perforation, anastomotic leak, or abdominal surgery
- amjcaserep.com
Clinically, the condition manifests with abdominal pain, tenderness, fever, and cloudy peritoneal effluent or ascitic fluid with marked neutrophilic pleocytosis
- nih.gov
Pathophysiologically, it is notable for severe local peritoneal injury, systemic inflammatory response, and an elevated risk of clinical failure due to the organism's intrinsic potential for inducible chromosomal AmpC beta-lactamase-mediated resistance
- nih.gov
Pathophysiologically, it is notable for severe local peritoneal injury, systemic inflammatory response, and an elevated risk of clinical failure due to the organism's intrinsic potential for inducible chromosomal AmpC beta-lactamase-mediated resistance
Personalize your experience
Follow Enterobacter peritonitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.